Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07771725Phase 1Not yet recruiting
Phase 1, randomised, double-blind trial of nicotine in Tobacco Use Disorder (TUD) (4 arms), sponsored by Yale University. Primary endpoints: Drug Discrimination Scale and Drug Effects Questionnaire pleasurable effects. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07771725.